AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate-MedSci.cn

AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate

Liu, XL; Chang, XY; Rothen, D; Derveni, M; Krenger, P; Roongta, S; Wright, E; Vogel, M; Tars, K; Mohsen, MO; Bachmann, MF

Liu, XL (corresponding author), Anhui Agr Univ, Int Immunol Ctr, Hefei 230036, Peoples R China.; Liu, XL; Mohsen, MO (corresponding author), Bern Univ Hosp, Dept Immunol, RIA, CH-3010 Bern, Switzerland.; Mohsen, MO (corresponding author), Univ Bern, Dept BioMed Res, CH-3012 Bern, Switzerland.; Mohsen, MO (corresponding author), Saiba AG, CH-8808 Pfaffikon, Switzerland.

VACCINES, 2021; 9 (4):

Abstract

COVID-19 is a novel disease caused by SARS-CoV-2 which has conquered the world rapidly resulting in a pandemic that massively impacts our health, soci......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate

科室

工具

服务